started · updated
Egyptian Drug Authority discusses regulatory coordination and technology localization
The Egyptian Drug Authority (EDA) is pursuing strategic initiatives to enhance regulatory oversight and modernize the pharmaceutical sector. Dr. Ali El-Ghamrawy, Chairman of the EDA, met with the National Food Safety Authority to discuss strengthening coordination and integration between the two bodies. The discussions focused on ensuring product safety and quality through scientific evidence and risk assessment, aiming to balance innovation with the availability of safe products for citizens.
In a separate effort to advance technological capabilities, the EDA held meetings with representatives from Roche Egypt, led by General Manager Stefano Mezzoni. The talks centered on digital transformation, the localization of pharmaceutical manufacturing, and the transfer of technology. Key topics included the potential application of artificial intelligence in regulatory affairs, capacity building through professional training programs, and alignment with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) standards.
Entities
Ali El-Ghamrawy · Egyptian Drug Authority · National Food Safety Authority · Roche Egypt · Stefano Mezzoni